Clinical Trials Browser

Phase 1/2 × INDUSTRY × Metastatic Solid Tumors × Clear all

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors

NCT03573544 2024-02-22

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Phase 1/2 Terminated

54 enrolled 16 charts

Other solid neoplasm

Metastatic Solid Tumors